Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

iShares Russell 2000 Growth ETF (IWO)

Delayed Data
As of Nov 27
 +0.73 / +0.50%
Today’s Change
Today|||52-Week Range

Investment Objective

The investment seeks to track the investment results of the Russell 2000 Growth Index, which measures the performance of the small-capitalization growth sector of the U.S. equity market. The fund generally invests at least 90% of its assets in securities of the underlying index and in depositary receipts representing securities of the underlying index. It may invest the remainder of its assets in certain futures, options and swap contracts, cash and cash equivalents, as well as in securities not included in the underlying index, but which the advisor believes will help the fund track the underlying index.


1 month+6.19% 3 years+18.27%
3 months+3.38% 5 years+13.51%
1 year+6.05% Since inception+4.60%
Data through 11/28/2015

Quote Details

Previous close$147.09
Open day’s range146.79 – 148.12
Net asset value (NAV)147.82 (11/27/2015)
Daily volume268,659
Average volume (3 months)1,041,056
Data as of 1:00pm ET, 11/27/2015

Peer Comparisonvs. Small growth ETFs

Performance 5-yr return+13.51%+13.84%
Expense Gross exp ratio0.25%0.32%
Risk 5 year sharpe ratio0.840.92
Net assets$6.7B$1.5B
Average market cap$1.6B$2.8B
Average P/E23.426.9
Dividend / Share--0.17%


IJT iShares S&P Small-Cap 600 Growth ETF
SLYG SPDR® S&P 600 Small Cap Growth ETF
VBK Vanguard Small-Cap Growth Index Fund ETF...


Top 5 Sectors
Portfolio weighting
Healthcare 16.90%
Industrial materials 12.87%
Hardware 11.74%
Consumer goods 11.16%
Consumer service 9.60%
Top 10 Holdings
Portfolio weighting
-- 0.74%
TYL Tyler Technologies Inc0.66%
MANH Manhattan Associates Inc0.62%
ANAC Anacor Pharmaceuticals Inc0.53%
MMS Maximus Inc0.52%
WST West Pharmaceutical Services Inc0.50%
TMH TeamHealth Holdings Inc0.50%
EEFT Euronet Worldwide Inc0.48%
MTN Vail Resorts Inc0.48%
NBIX Neurocrine Biosciences Inc0.48%